Spectranetics (ticker: SPNC, exchange: NASDAQ Global Market (.O))
News Release -
21-Jun-2006
Spectranetics to Present at the Jefferies Life Sciences Conference on June 27 COLORADO SPRINGS, Colo., June 21 /PRNewswire-FirstCall/ -- Spectranetics
Corporation (Nasdaq: SPNC) today announced that it will present at the
Jefferies Life Sciences Conference to be held June 27-28 at the Mandarin
Oriental Hotel in New York City.
John G. Schulte, Spectranetics' president and chief executive officer, is
scheduled to speak on Tuesday, June 27 at 2:30 p.m. Eastern time (11:30 a.m.
Pacific time) and will discuss the Company's strategic initiatives, product
pipeline and market opportunities.
Interested parties can access a live audio webcast at
www.spectranetics.com. An archived presentation will be available on the Web
site for 14 days.
About Spectranetics
Spectranetics is a medical device company that develops, manufactures and
markets single-use medical devices used in minimally invasive surgical
procedures within the cardiovascular system in conjunction with its
proprietary excimer laser system. Its CVX-300(R) excimer laser is the only
system approved by the FDA for multiple cardiovascular procedures, including
coronary atherectomy, and the removal of problematic pacemaker and
defibrillator leads. Nearly all of the company's FDA-approved and
investigational applications have received Communautes Europeennes (CE) mark
registration for marketing within Europe. In April 2004 Spectranetics
obtained 510(k) clearance from the FDA for the laser-based treatment of
patients suffering from total occlusions (blockages) in their leg arteries
that are not crossable with a guide wire.
COMPANY CONTACT:
Spectranetics Corporation
Guy Childs, Chief Financial Officer
(719) 633-8333
www.spectranetics.com
INVESTOR & MEDIA CONTACTS:
Lippert/Heilshorn & Associates, Inc.
Bruce Voss or Don Markley
(310) 691-7100
www.lhai.com
SOURCE Spectranetics Corporation
06/21/2006
CONTACT: Guy Childs, Chief Financial Officer of Spectranetics
Corporation, +1-719-633-8333; or Investors, Bruce Voss, or Don Markley, both
of Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, for Spectranetics
Corporation
Web site: http://www.lhai.com
Web site: http://www.spectranetics.com
(SPNC) |